找回密码
 To register

QQ登录

只需一步,快速开始

扫一扫,访问微社区

Titlebook: Radiopharmaceutical Therapy; Lisa Bodei,Jason S. Lewis,Brian M. Zeglis Book 2023 The Editor(s) (if applicable) and The Author(s), under ex

[复制链接]
查看: 46691|回复: 61
发表于 2025-3-21 16:15:02 | 显示全部楼层 |阅读模式
书目名称Radiopharmaceutical Therapy
编辑Lisa Bodei,Jason S. Lewis,Brian M. Zeglis
视频video
概述First book of its kind of to cover radiopharmaceutical therapy.Comprehensive and accessible introduction to a rapidly-growing field.Useful for a broad audience of scientists, researchers, physicians,
图书封面Titlebook: Radiopharmaceutical Therapy;  Lisa Bodei,Jason S. Lewis,Brian M. Zeglis Book 2023 The Editor(s) (if applicable) and The Author(s), under ex
描述.This book covers foundational topics in the emerging field of radiopharmaceutical therapy. It is divided into three sections: fundamentals, deeper dives, and special topics. In the first section, the authors examine the field from a bird’s-eye view, covering topics including the history of radiopharmaceutical therapy, the radiobiology of radiopharmaceutical therapy, and the radiopharmaceutical chemistry of both metallic and non-metallic radionuclides. The second section provides a more in-depth look at specific radiotherapeutics. Chapters include broader discussions of the different platforms for radiopharmaceutical therapy as well as more focused case studies covering individual radiotherapeutics. The third and final section explores a number of areas for further study, including medical physics, artificial intelligence, .in vivo .pretargeting, theranostic imaging, and the regulatory review process for radiotherapeutics..This book is the first of its kind andis useful for a broad audience of scientists, researchers, physicians, and students across a range of fields, including biochemistry, cancer biology, nuclear medicine, radiology, and radiation oncology..
出版日期Book 2023
关键词radiotherapy; cancer therapy; endoradiotherapy; radiopharmaceutical chemistry; Radiotherapeutics; Radioim
版次1
doihttps://doi.org/10.1007/978-3-031-39005-0
isbn_softcover978-3-031-39772-1
isbn_ebook978-3-031-39005-0
copyrightThe Editor(s) (if applicable) and The Author(s), under exclusive license to Springer Nature Switzerl
The information of publication is updating

书目名称Radiopharmaceutical Therapy影响因子(影响力)




书目名称Radiopharmaceutical Therapy影响因子(影响力)学科排名




书目名称Radiopharmaceutical Therapy网络公开度




书目名称Radiopharmaceutical Therapy网络公开度学科排名




书目名称Radiopharmaceutical Therapy被引频次




书目名称Radiopharmaceutical Therapy被引频次学科排名




书目名称Radiopharmaceutical Therapy年度引用




书目名称Radiopharmaceutical Therapy年度引用学科排名




书目名称Radiopharmaceutical Therapy读者反馈




书目名称Radiopharmaceutical Therapy读者反馈学科排名




单选投票, 共有 1 人参与投票
 

0票 0.00%

Perfect with Aesthetics

 

1票 100.00%

Better Implies Difficulty

 

0票 0.00%

Good and Satisfactory

 

0票 0.00%

Adverse Performance

 

0票 0.00%

Disdainful Garbage

您所在的用户组没有投票权限
发表于 2025-3-21 22:31:39 | 显示全部楼层
发表于 2025-3-22 03:50:12 | 显示全部楼层
978-3-031-39772-1The Editor(s) (if applicable) and The Author(s), under exclusive license to Springer Nature Switzerl
发表于 2025-3-22 04:52:31 | 显示全部楼层
Lisa Bodei,Jason S. Lewis,Brian M. ZeglisFirst book of its kind of to cover radiopharmaceutical therapy.Comprehensive and accessible introduction to a rapidly-growing field.Useful for a broad audience of scientists, researchers, physicians,
发表于 2025-3-22 09:07:33 | 显示全部楼层
The Production of Therapeutic Radionuclidesh the decay of long-lived radionuclides such as .U, .Th, and .U, upon which chemically distinct daughters can be separated for incorporation into radiopharmaceuticals. The rate of the production of a given radionuclide depends on the cross section of the nuclear reaction on the target material, the
发表于 2025-3-22 13:41:48 | 显示全部楼层
发表于 2025-3-22 17:46:55 | 显示全部楼层
发表于 2025-3-23 00:06:59 | 显示全部楼层
发表于 2025-3-23 05:23:38 | 显示全部楼层
Case Study #3: Antibody Fragments in Radiopharmaceutical Therapylity, unfavorable tissue distribution, and reduced binding affinity of radiolabeled antibody fragments have inhibited their widespread application in radiopharmaceutical therapy. In response, a great deal of effort has been dedicated to optimize the pharmacokinetics of antibody fragments (especially
发表于 2025-3-23 06:38:13 | 显示全部楼层
 关于派博传思  派博传思旗下网站  友情链接
派博传思介绍 公司地理位置 论文服务流程 影响因子官网 SITEMAP 大讲堂 北京大学 Oxford Uni. Harvard Uni.
发展历史沿革 期刊点评 投稿经验总结 SCIENCEGARD IMPACTFACTOR 派博系数 清华大学 Yale Uni. Stanford Uni.
|Archiver|手机版|小黑屋| 派博传思国际 ( 京公网安备110108008328) GMT+8, 2025-6-9 21:38
Copyright © 2001-2015 派博传思   京公网安备110108008328 版权所有 All rights reserved
快速回复 返回顶部 返回列表